VALIANT LABORATORIES LTD Share Price

VALIANT LABORATORIES LTD Share Price

NSE: VALIANTLAB
|
Pharmaceuticals
|
S Cap
₹ 78.49
+₹3.73 (4.99%)
1D
Last updated 13 Aug, 2026, 15:29 IST

VALIANT LABORATORIES LTD Share Price Today

As of 14 Aug 2026, VALIANT LABORATORIES LTD share price is ₹78.49. The stock opened at ₹78.49, compared to its previous close of ₹74.76. During today's trading session, VALIANT LABORATORIES LTD share price moved in the range of ₹78.49 to ₹78.49, with an average price of ₹78.49 for the day. Looking at its last 52-week, the stock has touched a low of ₹49.51 and a high of ₹100.98. On the performance front, VALIANT LABORATORIES LTD share price has increased by 28.19% over the last six months and is down 10.84% on a year-on-year basis.

₹78.49
4.99% up today
₹78.49
1D LOW
1D HIGH

VALIANT LABORATORIES LTD Returns Calculator

Circuit
L
H
₹71.03
₹78.49
52-week
L
H
₹49.51
₹100.98

About VALIANT LABORATORIES LTD

VALIANT LABORATORIES LTD Share Price
ISIN
INE0JWS01017
Sector Market Cap
₹ 409.19 Cr

Valiant Laboratories Limited is an India-based pharmaceutical ingredient manufacturing company. The Company is focused on manufacturing a Paracetamol active pharmaceutical ingredient (API)/bulk drug. It has several applications in the treatment of conditions such as headache, muscle ache, arthritis, backache, toothache, cold and fever. It is also used in the management of severe pain such as post-surgical and cancer pain. It operates a single-location manufacturing facility on the Tarapur industrial estate.

VALIANT LABORATORIES LTD Financial Highlights

  • Revenue: VALIANT LABORATORIES LTD reported revenue of ₹239.79 crore in FY26 vs ₹138.81 crore in FY25. It showed an increase of 72.75% on a yearly basis.
  • Operating Profit: VALIANT LABORATORIES LTD reported an operating profit of ₹0.77 crore in FY26 vs ₹1.51 crore in FY25. It showed an increase of 150.99% on a year-on-year basis.
  • Net Profit: VALIANT LABORATORIES LTD reported a net loss of ₹3.27 crore in FY26 vs ₹2.20 crore in FY25. It showed a decrease of 48.64% on a yearly basis.

VALIANT LABORATORIES LTD Quarterly Result Highlights

  • VALIANT LABORATORIES LTD reported revenue of ₹92.15 crore in Mar 2026, compared with ₹53.09 crore in Dec 2025, representing an increase of 73.57% on a quarter-on-quarter (QoQ) basis.
  • VALIANT LABORATORIES LTD reported an operating profit of ₹1.05 crore in Mar 2026, compared with ₹2.99 crore in Dec 2025, representing an increase of 135.12% on a quarter-on-quarter (QoQ) basis.
  • VALIANT LABORATORIES LTD reported a profit of ₹1.76 crore in Mar 2026, compared with ₹7.06 crore in Dec 2025, reflecting an increase of 124.93% on a QoQ basis.
  • The earnings per share (EPS) of VALIANT LABORATORIES LTD stood at ₹0.51 during Mar 2026.
Know more
Promoters
74.94%
FII
0.00%
Other DII
0.00%
Retail and other
25.06%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Sep 20250.02%
Dec 20250.01%
Mar 20260.20%
Jun 20260.00%
Mkt Cap Cr
409.19
P/E
25.54
P/B
1.32
ROE
-1.05%
D/E
0.00
ROCE
0.74%
Div. Yield
0.00%
EPS(TTM)
1.02
Turnover
0.62
EV/EBITDA
11.90
Net Margin
0.00%
Op. Margin
0.00%
ROA
3.45%
Quick Ratio
0.00
Curr. Ratio
3.04
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Valiant Laborato outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Valiant Laborato appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Valiant Laborato revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,64,271.0038.325.5613.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,26,843.0077.5513.5315.32%0.0019.56%629.490.35%0.5598.19
Torrent Pharmaceuticals1,86,000.0086.2722.1225.49%1.6913.85%222.760.69%0.4958.70
Zydus Lifesciences1,20,099.0026.154.4318.59%0.3117.35%237.300.08%0.3335.38
Cipla1,18,027.0035.183.4311.27%0.0014.95%423.360.89%0.4543.52
Lupin1,03,549.0018.654.6123.76%0.0424.88%659.050.79%0.57129.18
Mankind Pharma1,00,137.0048.436.1411.74%0.3413.13%397.020.04%0.4449.37
Dr. Reddy's Laboratories1,00,073.0031.442.6311.07%0.1812.54%377.960.67%0.4138.68
Laurus Labs99,474.2091.2318.7716.77%0.4016.14%97.200.11%0.6713.72
Aurobindo Pharma96,700.6026.062.559.25%0.1911.76%391.140.24%0.3841.58

VALIANT LABORATORIES LTD Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Revenue₹133.38₹182.06₹333.91
Other Income₹5.43₹9.68₹4.86
Total Revenue₹138.82₹191.74₹338.77
Total Expenses₹140.33₹192.51₹300.64
Profit Before Tax-₹1.51-₹0.77₹38.14
Tax₹0.69-₹1.09₹9.14
Profit After Tax-₹2.20₹0.32₹29.00
EPS - Basic-₹0.51₹0.13₹8.91
EPS - Diluted-₹0.51₹0.13₹8.91

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Profit before tax-₹1.51-₹0.77₹38.14
Income before WC changes₹2.78₹1.27₹39.69
Change in Assets-₹18.87₹22.89₹20.14
Change in Liabilities₹14.94-₹23.26₹5.02
Change in WC-₹3.93-₹0.37₹25.16
Cash flow from Operations₹1.31₹1.89₹56.05
Cash flow from Investing-₹52.77-₹143.88-₹55.17
Cash flow from Financing₹44.65₹152.45-₹0.93
Total Cash Flow-₹6.80₹10.46-₹0.05
Cash (Start of the year)₹11.72₹1.26₹1.31
Cash (End of the year)₹4.92₹11.72₹1.26

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Non-Current Assets₹208.24₹117.14₹62.39
Current Assets₹192.62₹225.54₹150.58
Total Assets₹400.86₹342.69₹212.97
Current Liabilities₹59.62₹29.08₹50.73
Net Current Asset₹133.00₹196.47₹99.85
Non-Current Liabilities₹106.93₹76.75₹61.75
Equity Capital₹234.31₹236.86₹100.49
Total Equity & Liabilities₹400.86₹342.69₹212.97

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹133.36₹182.05₹333.91₹291.52
Other Income₹5.43₹9.68₹4.86₹1.95
Total Revenue₹138.79₹191.73₹338.77₹293.47
Total Expenses₹140.24₹192.49₹300.64₹251.77
Profit Before Tax-₹1.45-₹0.75₹38.14₹41.70
Tax₹0.70-₹1.09₹9.14₹14.21
Profit After Tax-₹2.15₹0.34₹29.00₹27.50
EPS - Basic-₹0.50₹0.14₹8.91₹9.52
EPS - Diluted-₹0.50₹0.14₹8.91₹9.52

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹1.45-₹0.75₹38.14₹41.70
Income before WC changes₹2.77₹1.27₹39.95₹44.77
Change in Assets-₹22.27₹70.90-₹7.39-₹79.76
Change in Liabilities-₹5.59-₹24.37-₹0.81₹51.71
Change in WC-₹27.86₹46.53-₹8.20-₹28.05
Cash flow from Operations-₹21.90₹48.78₹22.96₹2.25
Cash flow from Investing₹24.97-₹182.73-₹21.18-₹12.24
Cash flow from Financing-₹0.50₹135.80-₹1.53₹6.18
Total Cash Flow₹2.57₹1.85₹0.24-₹3.81
Cash (Start of the year)₹2.23₹0.38₹0.13₹3.94
Cash (End of the year)₹4.80₹2.23₹0.38₹0.13

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹198.06₹115.46₹30.80₹25.02
Current Assets₹119.22₹209.27₹181.96₹156.80
Total Assets₹317.28₹324.73₹212.76₹181.81
Current Liabilities₹20.95₹26.36₹50.52₹49.43
Net Current Asset₹98.27₹182.90₹131.44₹107.37
Non-Current Liabilities₹61.95₹61.48₹61.75₹60.93
Equity Capital₹234.38₹236.88₹100.49₹71.46
Total Equity & Liabilities₹317.28₹324.73₹212.76₹181.81
* All values are in INR Crore
Qty
Bid
78392
78.49
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 78392
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
5
Neutral
1
Bullish
2
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
76.78
Bullish
ATR (14)
2.83
Neutral
STOCH(9,6)
100
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
52.21
Bearish
UO(9)
79.75
Bearish
ROC(12)
21.54
Bullish
WillR(14)
0
Bearish
Period
Simple value
Exponential vaue
5D
67.98
69.31
10D
64.61
66.49
20D
63.51
64.96
50D
65.72
65.74
100D
67.5
66.29
Volume trend — traded volume by day
13 Aug0L
12 Aug0L
11 Aug0L
10 Aug0L
7 Aug0L
Average0L
Compare against other stocks
VALIANT LABORATORIES LTD Share Price
VALIANT LABORATORIES LTD
Pharmaceuticals
Add Stock
Add Another

VALIANT LABORATORIES LTD Share Price FAQs